Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership233,500 shares
Latest Disclosed Value $ 30,761,290
Bnp Paribas Arbitrage, Sa ownership in NBIX / Neurocrine Biosciences, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 233,500 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $30,761,290 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 213,992 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 9.12% during the quarter.

Bnp Paribas Arbitrage, Sa has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Neurocrine Biosciences Equity 64125C109 233,500 19,508 9.12 30,761 1.35 0.0015
2026-02-10 2025-12-31 13F Neurocrine Biosciences Equity 64125C109 213,992 113,017 111.93 30,350 114.12 0.0138
2025-11-13 2025-09-30 13F Neurocrine Biosciences Equity 64125C109 100,975 -13,210 -11.57 14,175 -1.23 0.0076
2025-08-14 2025-06-30 13F Neurocrine Biosciences Equity 64125C109 114,185 -123,030 -51.86 14,352 -45.30 0.0082
2025-05-14 2025-03-31 13F Neurocrine Biosciences Equity 64125C109 237,215 -52,625 -18.16 26,236 -33.69 0.0154
2025-02-14 2024-12-31 13F Neurocrine Biosciences Equity 64125C109 289,840 -243,484 -45.65 39,563 -35.62 0.0222
2024-11-13 2024-09-30 13F Neurocrine Biosciences Equity 64125C109 533,324 102,715 23.85 61,450 3.66 0.0413
2024-08-13 2024-06-30 13F Neurocrine Biosciences Equity 64125C109 430,609 -1,373 -0.32 59,282 -0.50 0.0483
2024-05-01 2024-03-31 13F Neurocrine Biosciences Equity 64125C109 431,982 124,352 40.42 59,579 46.99 0.0523
2024-02-14 2023-12-31 13F/A-2 Neurocrine Biosciences Equity 64125C109 307,630 29,889 10.76 40,533 29.73 0.0460
2024-02-07 2023-12-31 13F/A-1 Neurocrine Biosciences Equity 64125C109 307,630 29,889 40,533 0.0057
2024-02-07 2023-12-31 13F Neurocrine Biosciences Equity 64125C109 307,630 40,533
2023-11-14 2023-09-30 13F Neurocrine Biosciences Equity 64125C109 277,741 57,260 25.97 31,246 50.28 0.0401
2023-08-09 2023-06-30 13F Neurocrine Biosciences Equity 64125C109 220,481 -21,201 -8.77 20,791 -15.01 0.0260
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 241,682 43,143 21.73 24,463 3.16 0.0343
2023-02-14 2022-12-31 13F Neurocrine Biosciences Equity 64125C109 198,539 68,480 52.65 23,713 71.67 0.0364
2022-11-16 2022-09-30 13F/A-1 Neurocrine Biosciences Equity 64125C109 130,059 64,179 97.42 13,814 115.12 0.0221
2022-11-15 2022-09-30 13F Neurocrine Biosciences Equity 64125C109 130,059 64,179 13,814 0.0033
2022-08-12 2022-06-30 13F Neurocrine Biosciences Equity 64125C109 65,880 15,254 30.13 6,422 35.29 0.0100
2022-05-18 2022-03-31 13F/A-1 Neurocrine Biosciences Equity 64125C109 50,626 -260,316 -83.72 4,746 -82.08 0.0064
2022-02-09 2021-12-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 310,942 20,406 7.02 26,483 -4.96 0.0377
2021-11-16 2021-09-30 13F/A-1 NEUROCRINE BIOSCIENCES EQUITY 64125C109 290,536 -1,436 -0.49 27,865 -1.93 0.0395
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 35,557 -256,415 3,419 0.0000
2021-08-10 2021-06-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 291,972 153,176 110.36 28,415 110.52 0.0376
2021-05-07 2021-03-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 138,796 82,172 145.12 13,498 148.70 0.0197
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 56,624 21,067 59.25 5,427 58.73 0.0101
2020-10-30 2020-09-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 35,557 -25,923 -42.16 3,419 -54.41 0.0049
2020-08-06 2020-06-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 61,480 15,715 34.34 7,501 89.39 0.0132
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 45,765 -2,862 -5.89 3,961 -24.23 0.0081
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 48,627 37,884 352.64 5,227 439.88 0.0095
2019-11-07 2019-09-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 10,743 706 7.03 968 14.29 0.0017
2019-07-30 2019-06-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 10,037 -22 -0.22 847 -4.40 0.0017
2019-04-25 2019-03-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 10,059 -9,549 -48.70 886 -36.71 0.0019
2019-02-12 2018-12-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 19,608 10,073 105.64 1,400 19.45 0.0033
2018-11-07 2018-09-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 9,535 -1,181 -11.02 1,172 11.41 0.0017
2018-07-25 2018-06-30 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 10,716 -15,194 -58.64 1,053 -51.02 0.0018
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 25,910 -32,074 -55.32 2,149 -52.25 0.0040
2018-03-05 2017-12-31 13F/A-1 NEUROCRINE BIOSCIENCES EQUITY 64125C109 57,984 -33,489 -36.61 4,499 -19.75 0.0080
2018-02-01 2017-12-31 13F NEUROCRINE BIOSCIENCES EQUITY 64125C109 57,984 -33,489 4,499
2017-11-03 2017-09-30 13F NEUROCRINE BIOSCIENCES STOCK 64125C109 91,473 19,103 26.40 5,605 68.37 0.0137
2017-08-03 2017-06-30 13F NEUROCRINE BIOSCIENCES STOCK 64125C109 72,370 57,705 393.49 3,329 425.08 0.0100
2017-05-03 2017-03-31 13F NEUROCRINE BIOSCIENCES STOCK 64125C109 14,665 1,890 14.79 635 28.34 0.0017
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES STOCK 64125C109 12,775 -1,697 -11.73 494 -32.51 0.0023
2016-10-05 2016-09-30 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 14,472 1,736 13.63 733 26.64 0.0030
2016-07-06 2016-06-30 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 12,736 583 4.80 579 20.42 0.0026
2016-04-22 2016-03-31 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 12,153 3,638 42.72 481 -0.21 0.0020
2016-04-19 2015-12-31 13F/A-1 * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 8,515 -8,944 -51.23 482 -30.69 0.0023
2016-02-10 2015-12-31 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 8,515 482
2015-11-13 2015-09-30 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 17,459 10,353 145.69 695 104.72 0.0017
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 7,106 5,100 254.24 339 329.11 0.0009
2015-05-15 2015-03-31 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 2,006 2,006 0.00 80 0.0002
2015-02-11 2014-12-31 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 0 -4,512 -100.00 0 -100.00
2014-11-12 2014-09-30 13F * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 4,512 4,349 2,668.10 71 3,400.00 0.0001
2014-08-14 2014-06-30 13F/A-1 * NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 163 133 443.33 2 -99.52 0.0000
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES INC COM STOCK 64125C109 163 2
2014-05-13 2014-03-31 13F NEUROCRINE BIOSCIENCES STOCK 64125C109 30 -836 -96.54 0 -100.00 0.0000
2014-04-02 2013-12-31 13F/A-1 NEUROCRINE BIOSCIENCES STOCK 64125C109 866 -17,414 -95.26 8 -96.12 0.0000
2013-11-13 2013-09-30 13F NEUROCRINE BIOSCIENCES STOCK 64125C109 18,280 -4,713 -20.50 207 -32.90 0.0002
2013-08-13 2013-06-30 13F NEUROCRINE BIOSCIENCES STOCK 64125C109 22,993 22,993 308 0.0002
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-09 2021-12-31 13F NEUROCRINE BIOSCIENCES OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES OPTION Put 100 962 n/a n/a n/a
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-10-30 2020-09-30 13F NEUROCRINE BIOSCIENCES OPTION Put 100 -33.33 962 -47.49 n/a n/a n/a
2020-08-06 2020-06-30 13F NEUROCRINE BIOSCIENCES OPTION Put 150 -67.74 1,830 -54.52 n/a n/a n/a
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES OPTION Put 465 4,025 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.